Wu Yunhao, Li Yan, Li Hongxia, Wang Tao, Huang Peng, Wu Yiwen, Sun Bomin, Pan Yixin, Li Dianyou
Department of Neurosurgery, Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Heliyon. 2024 May 17;10(10):e31475. doi: 10.1016/j.heliyon.2024.e31475. eCollection 2024 May 30.
Deep brain stimulation (DBS) of subthalamic nucleus (STN) has been well-established and increasingly applied in patients with isolated dystonia. Nevertheless, the surgical efficacy varies among patients. This study aims to explore the factors affecting clinical outcomes of STN-DBS on isolated dystonia and establish a well-performed prediction model.
In this prospective study, thirty-two dystonia patients were recruited and received bilateral STN-DBS at our center. Their baseline characteristics and up to one-year follow-up outcomes were assessed. Implanted electrodes of each subject were reconstructed with their contact coordinates and activated volumes calculated. We explored correlations between distinct clinical characteristics and surgical efficacy. Those features were then trained for the model in outcome prediction via support vector regression (SVR) algorithm and testified through cross-validation.
Patients demonstrated an average clinical improvement of 56 ± 25 % after STN-DBS, significantly affected by distinct symptom forms and activated volumes. The optimal targets and activated volumes were concentratedly located at the dorsal posterior region to STN. Most patients had a rapid response to STN-DBS, and their motor score improvement within one week was highly associated with long-term outcomes. The trained SVR model, contributed by distinct weights of features, could reach a maximum prediction accuracy with mean errors of 11 ± 7 %.
STN-DBS demonstrated significant and rapid therapeutic effects in patients with isolated dystonia, by possibly affecting the pallidofugal fibers. Early improvement highly indicates the ultimate outcomes. SVR proves valid in outcome prediction. Patients with predominant phasic and generalized symptoms, shorter disease duration, and younger onset age may be more favorable to STN-DBS in the long run.
丘脑底核(STN)的深部脑刺激(DBS)已得到充分确立,并越来越多地应用于孤立性肌张力障碍患者。然而,手术疗效在患者之间存在差异。本研究旨在探讨影响STN-DBS治疗孤立性肌张力障碍临床结局的因素,并建立一个性能良好的预测模型。
在这项前瞻性研究中,招募了32例肌张力障碍患者并在我们中心接受双侧STN-DBS治疗。评估了他们的基线特征和长达一年的随访结果。对每个受试者植入的电极进行重建,计算其触点坐标和激活体积。我们探讨了不同临床特征与手术疗效之间的相关性。然后通过支持向量回归(SVR)算法对这些特征进行模型训练以预测结局,并通过交叉验证进行验证。
患者在STN-DBS后平均临床改善率为56±25%,受不同症状形式和激活体积的显著影响。最佳靶点和激活体积集中位于STN的背侧后部区域。大多数患者对STN-DBS反应迅速,他们在一周内的运动评分改善与长期结局高度相关。经过训练的SVR模型,由不同特征权重贡献,可达到最大预测准确率,平均误差为11±7%。
STN-DBS在孤立性肌张力障碍患者中显示出显著且快速的治疗效果,可能是通过影响苍白球传出纤维。早期改善高度预示最终结局。SVR在结局预测中被证明是有效的。从长远来看,以阶段性和全身性症状为主、病程较短且发病年龄较轻的患者可能对STN-DBS更有利。